Centre de Recherche Dermatologique du Quebec metropolitain
Quebec, Canada
Research institute in Quebec City, Quebec
2880 Chem. des Quatre-Bourgeois, Québec, QC G1V 4X7
About Centre de Recherche Dermatologique du Quebec metropolitain
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
16
Innovaderm Research Inc.
6
Amgen
2
Bristol-Myers Squibb
2
Concert Pharmaceuticals
2
Dermira, Inc.
2
Eli Lilly and Company
2
Janssen Research & Development, LLC
2
LEO Pharma
2
ASLAN Pharmaceuticals
1
AnaptysBio, Inc.
1
Clinical Trials at Centre de Recherche Dermatologique du Quebec metropolitain
During the past decade, Centre de Recherche Dermatologique du Quebec metropolitain conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 22 clinical trials were completed, i.e. on
average, 88% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 11 clinical trials were completed. i.e. 137.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmoplantar Pustulosis
2006-04-01
2007-03-01
Completed
15
Safety and Efficacy of Infliximab in Palmoplantar Psoriasis
2007-03-01
2009-07-01
Completed
24
Safety and Efficacy of Combining nbUVB to Etanercept in Patients
2008-04-01
2010-03-01
Completed
99
Tolerance and Efficacy of Formulation 609580 20 Versus Formulation 609209 in Children With Atopic Dermatitis
2009-01-01
2009-07-01
Terminated
73
Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments
2009-09-01
2014-07-01
Completed
89
Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis
2009-11-01
2011-12-01
Completed
870
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centre de Recherche Dermatologique du Quebec metropolitain" #1 sponsor was "Pfizer" with 16 trials, followed by "Innovaderm Research Inc." with 6 trials
sponsored, "Amgen" with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Concert Pharmaceuticals"
with 2 trials sponsored. Other sponsors include 13 different institutions and
companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centre de Recherche Dermatologique du Quebec metropolitain"
#1 collaborator was "Amgen" with 4 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Innovaderm Research Inc." with 1 trials as a collaborator, "Janssen-Ortho LLC" with 1 trials as a collaborator and "Schering-Plough" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Centre de Recherche Dermatologique du Quebec metropolitain
According to Clinical.Site data, the most researched conditions in "Centre de Recherche Dermatologique du Quebec metropolitain" are
"Psoriasis" (11 trials), "Atopic Dermatitis" (9 trials), "Dermatitis, Atopic" (5 trials), "Alopecia Areata" (4 trials) and "Plaque Psoriasis" (3 trials). Many other conditions were trialed in "Centre de Recherche Dermatologique du Quebec metropolitain" in a lesser frequency.
Clinical Trials Intervention Types at Centre de Recherche Dermatologique du Quebec metropolitain
Most popular intervention types in "Centre de Recherche Dermatologique du Quebec metropolitain" are "Drug" (42 trials), "Other" (8 trials), "Biological" (3 trials), "Device" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (16 trials), "Apremilast" (3 trials), "CP-690,550" (3 trials), "Abrocitinib 200 mg" (2 trials) and "BMS-986165" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Centre de Recherche Dermatologique du Quebec metropolitain
The vast majority of trials in "Centre de Recherche Dermatologique du Quebec metropolitain" are
46 trials for "All" genders.
Clinical Trials Status at Centre de Recherche Dermatologique du Quebec metropolitain
Currently, there are NaN active trials in "Centre de Recherche Dermatologique du Quebec metropolitain".
undefined are not yet recruiting,
1 are recruiting,
5 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 32 completed trials in Centre de Recherche Dermatologique du Quebec metropolitain,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Centre de Recherche Dermatologique du Quebec metropolitain, 2 "Phase 1"
clinical trials were conducted, 22 "Phase 2" clinical
trials and 20 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 1 trials that are defined as “Not Applicable".